Advertisement

Agents of Biological and Chemical Terrorism

  • Michael T. MeyerEmail author
  • Philip C. Spinella
  • Ted Cieslak
Chapter

Abstract

Children have myriad unique needs compared to adults during all types of disasters. Many of these unique needs emanate from the fundamental differences between adults and children in terms of anatomy and physiology. In the event of a biological or chemical terrorism event, the difficulties which arise from these differences are complicated by a lack of weight-based medication dosing guidelines, a lack of appropriate sized supplies, and a lack of evidence-based practices in children. The risk of biological, chemical, or radiological weapon use has increased as terrorists become more familiar with these agents and their potential for harm. Biological agents are invisible to the eye, odorless, potentially lethal in particulate form; natural organisms are readily available, and can be disguised as natural disasters to spread fear and disease. Chemical agents rapidly attack the body’s critical physiological centers, disabling or killing victims. Potential biochemical agents of terrorism include; Bacillus anthracis (anthrax), Yersinia pestis (plague), tularemia, small pox, botulinum toxin, nerve agents and cyanide. Healthcare providers need to be familiar with clinical presentation and life-saving treatment modalities, as well as the precautions necessary to prevent contamination and transmission to healthcare workers and to proactively plan for the needs of children during a disaster.

Keywords

Biological weapons Chemical weapons Nerve agents Small pox Category A agents 

Notes

Disclaimer

The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as necessarily reflecting the views of the U.S. Department of Defense, the U.S. Department of Health and Human Services, or their component services, agencies, and institutions.

References

  1. 1.
    Pettineo C, Aitchison R, Leikin SM, Vogel SN, Leikin JB. Biological and chemical weapons of mass destruction: updated clinical therapeutic countermeasures since 2003. Am J Ther. 2009;16(1):35–43.PubMedCrossRefGoogle Scholar
  2. 2.
    Stokes E, Gilbert-Palmer D, Young C, Persell D. Chemical agents of terrorism: preparing nurse practitioners. Nurs Pract. 2004;29(5):30–9.CrossRefGoogle Scholar
  3. 3.
    Baker DJ. Critical care requirements after mass toxic agent release. Crit Care Med. 2005;33(1):S66–74.PubMedCrossRefGoogle Scholar
  4. 4.
    Pavlin JA. Epidemiology of bioterrorism. Emerg Infect Dis. 1999;5:528–30.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Cieslak TJ, Henreitig FM. Medical consequences of biological warfare: the ten commandments of management. Mil Med. 2001;166(S2):11–2.PubMedGoogle Scholar
  6. 6.
    Cieslak TJ, Christopher GW, Eitzen EM. Bioterrorism alert for healthcare workers. In: Fong IW, Alibek K, editors. Bioterrorism and infectious agents: a new dilemma for the 21st century. New York: Springer Science & Business Media Inc; 2005. p. 215–34.Google Scholar
  7. 7.
    Emmad NA, Udeani JC. Biologic toxins. Top Emerg Med. 2002;24(2):72–8.Google Scholar
  8. 8.
    Bronze MS, Huycke MM, Machado LJ, Voskuhl GW, Greenfield RA. Viral agents as biological weapons and agents of bioterrorism. Am J Med Sci. 2002;323(6):316–25.PubMedCrossRefGoogle Scholar
  9. 9.
    Dang C, Kare J, Shneiderman A, Dang ABC. Chemical warfare agents. Top Emerg Med. 2002;24(2):25–39.Google Scholar
  10. 10.
    American Academy of Pediatrics, Committee on Environmental Health, Committee on Infectious Diseases. Chemical-biological terrorism and its impact on children: a subject review. Pediatrics. 2000;105:662–70.CrossRefGoogle Scholar
  11. 11.
    Greenfield RA, Drevets DA, Machado LJ, Voskuhl GW, Cornea P, Bronze MS. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci. 2002;323(6):299–315.PubMedCrossRefGoogle Scholar
  12. 12.
    Foltin G, Tunik M, Curran J, Marshall L, Bove J, van Amerongen R, et al. Pediatric nerve agent poisoning: medical and operational considerations for emergency medical services in a large American city. Pediatr Emerg Care. 2006;22(4):239–44.PubMedCrossRefGoogle Scholar
  13. 13.
    Gamble MS, Hanners RB, Lackey C, Beaudin CL. Leadership and hospital preparedness: disaster management and emergency services in pediatrics. J Trauma. 2009;67(2):S79–83.PubMedCrossRefGoogle Scholar
  14. 14.
    Ciraulo DL, Frykberg ER, Feliciano DV, Knuth TE, Richart CM, Westmoreland CD, Williams KA. A survey assessment of the level of preparedness for domestic terrorism and mass casualty incidents among eastern association for the surgery of trauma members. J Trauma. 2004;56(5):1033–41.PubMedCrossRefGoogle Scholar
  15. 15.
    Lynch EL, Thomas TL. Pediatric considerations in chemical exposures: are we prepared? Pediatr Emerg Care. 2004;20(3):198–208.PubMedCrossRefGoogle Scholar
  16. 16.
    Kabsai D, Kare J. Prehospital disaster management: implications for weapons of mass destruction. Top Emerg Med. 2002;24(3):37–43.Google Scholar
  17. 17.
    Karwa M, Currie B, Kvetan V. Bioterrorism: preparing for the impossible or the improbable. Crit Care Med. 2005;33(1):S75–95.PubMedCrossRefGoogle Scholar
  18. 18.
    Montello MJ, Tarosky M, Pincock L, Montello N, Hess WA, Velazquez L, et al. Dosing cards for the treatment of children exposed to weapons of mass destruction. Am J Health Syst Pharm. 2006;63(15):944–9.PubMedCrossRefGoogle Scholar
  19. 19.
    US Army Medical Research Institute of Chemical Defense. Field management of chemical casualties. 2nd ed. Aberdeen Proving Ground: Chemical Casualty Care Division USAMRICD; 2000. p. 96–135.Google Scholar
  20. 20.
    US Army Medical Research Institute of Infectious Diseases. Medical management of biological casualties handbook. 6th ed. Fort Detrick, Frederick: US Army Medical Research Institute of, Infectious Diseases; 2005. p. 33–48.Google Scholar
  21. 21.
    CDC. Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2002;51:1024–6.Google Scholar
  22. 22.
    Nowara WWS, Samet JM, Rosario PA. Early and late pulmonary complications of botulism. Arch Intern Med. 1983;143:451–6.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  • Michael T. Meyer
    • 1
    Email author
  • Philip C. Spinella
    • 2
  • Ted Cieslak
    • 3
  1. 1.Division of Pediatric Critical Care MedicineMedical College of Wisconsin, Children’s Hospital of WisconsinMilwaukeeUSA
  2. 2.Division of Critical Care, Critical Care Translation Research ProgramWashington University in St. Louis Medical SchoolSt. LouisUSA
  3. 3.Clinical Services DivisionUS Army Medical Command, Army Surgeon GeneralFort Sam HoustonUSA

Personalised recommendations